Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: Do they merit further study?

Journal of Neuro-Ophthalmology

Volumn 27, Issue 3, 2007, Pages 161-163

  Kelman, Shalom E ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Maryland Neuroophthalmology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE; VASCULOTROPIN;

BLINDNESS; CLINICAL TRIAL; DECOMPRESSION SURGERY; EDITORIAL; HUMAN; ISCHEMIC OPTIC NEUROPATHY; NERVE SHEATH; NERVE SHEATH DECOMPRESSION; NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY; OPTIC NERVE; PAPILLEDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; HUMANS; INJECTIONS; OPHTHALMOLOGIC SURGICAL PROCEDURES; OPTIC NERVE; OPTIC NEURITIS; OPTIC NEUROPATHY, ISCHEMIC; PAPILLEDEMA; PILOT PROJECTS; TREATMENT OUTCOME; TRIAMCINOLONE; VITREOUS BODY;

EID: 34748875957     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e31814a61ae     Document Type: Editorial

References (12)

1. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-32.
2. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317-28.
3. Kaderli B, Avci R, Yucel A, et al. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2007;27:164-68.
4. Bennett JL, Thomas S, Olson JL, et al. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol 2007;27:238-40.
5. Sergott RC, Savino PJ, Bosley TM. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988;106:1384-90.
6. Sergott RC, Cohen MS, Bosley TM, et al. Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol 1989;107:1743-54.
7. Kelman SE, Elman MJ. Optic nerve sheath decompression for nonarteritic ischemic optic neuropathy improves multiple visual function measurements. Arch Ophthalmol 1991;109:667-71.
8. Hayreh SS. The role of optic nerve sheath fenestration in management of anterior ischemic optic neuropathy. Arch Ophthalmol 1990;108:1063-5.
9. Levin LA. Clarifying the treatment of nonarteritic anterior ischemic optic neuropathy. JAMA 1995;273:666-7.
10. Bernstein SL, Guo Y, Kelman SE, et al. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci 2003;44:4153-62.
11. Bernstein SL, Guo Y, Slater BJ, et al. Neuron stress and loss following rodent anterior ischemic optic neuropathy in doublereporter transgenic mice. Invest Ophthalmol Vis Sci 2007;48:2304-10.
12. Bernstein SL, Chen C, Miller NR, et al. A primate model of nonarteritic anterior ischemic optic neuropathy (pNAION). Invest Ophthalmol Vis Sci 2007;48:E-Abstract 4410.